Baycox 50 mg Suspension is a Health Canada–registered veterinary drug (DIN 02355353) held by Elanco Canada Limited, containing Toltrazuril. Health Canada lists its status as Marketed (status date 09 Dec 2021). Nexara Health has matched 53 registrations of Toltrazuril across 5 other regulated markets.
Health Canada registration
| DIN | 02355353 |
|---|---|
| Brand name | Baycox |
| Active ingredient | Toltrazuril |
| Strength | 50 mg |
| Dosage form | Suspension |
| Route | Oral |
| Company | Elanco Canada Limited |
| Status | Marketed — 09 Dec 2021 |
| Class | Veterinary |
| ATC | |
| AHFS | |
| Regulator record | Health Canada DPD entry · Product monograph |
Toltrazuril registered in other markets
53 registrations of the same molecule in 5 national registries outside Canada (first 30 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Denmark | Baycoxine Vet. | Elanco Animal Health GmbH | 50 mg/ml | oral suspension | Decentral procedure | Laegemiddelstyrelsen |
| Denmark | Cevazuril | Ceva Sante Animale | 50 mg/ml | oral suspension | Decentral procedure | Laegemiddelstyrelsen |
| Denmark | Dozuril | Dopharma Research B.V. | 25 mg/ml | opløsning til anvendelse i drikkevand | Decentral procedure | Laegemiddelstyrelsen |
| Denmark | Dozuril | Dopharma Research B.V. | 50 mg/ml | oral suspension | Decentral procedure | Laegemiddelstyrelsen |
| Denmark | Espacox | Industrial Veterinaria S.A. | 50 mg/ml | oral suspension | Decentral procedure | Laegemiddelstyrelsen |
| Denmark | Toltarox | KRKA d.d. Novo mesto | 50 mg/ml | oral suspension | Decentral procedure | Laegemiddelstyrelsen |
| Denmark | Toltranil | KRKA d.d. Novo mesto | 50 mg/ml | oral suspension | Decentral procedure | Laegemiddelstyrelsen |
| Denmark | Zorabel | Vetpharma Animal Health, S.L. | 50 mg/ml | oral suspension | Decentral procedure | Laegemiddelstyrelsen |
| Iceland | Baycoxine vet | Elanco Animal heath GmbH | 50 mg/ml | mixtúra | 0 | Lyfjastofnun lyfjaverdskra |
| Iceland | Baycoxine vet | Elanco Animal heath GmbH | 50 mg/ml | mixtúra | 0 | Lyfjastofnun lyfjaverdskra |
| Malaysia | AVIACOX 2.5% w/v SOLUTION | Range Pharma Sdn. Bhd. | Veterinary | PRODUCT APPROVED | NPRA | |
| Malaysia | Baycox 5% w/v Oral Suspension | Elanco Malaysia Sdn Bhd | Veterinary | PRODUCT APPROVED | NPRA | |
| Malaysia | ESPACOX 50mg/ml Oral Suspension | Yenher Agro-products Sdn. Bhd. | Veterinary | PRODUCT APPROVED | NPRA | |
| Malaysia | MEDI-COC 50 (Toltrazuril 5% Oral Suspension) | GNC Agritech Sdn Bhd | Veterinary | PRODUCT APPROVED | NPRA | |
| Malaysia | Metatoltra 2.5% w/v Oral Solution | Nutri Pharmax Sdn Bhd | Veterinary | PRODUCT APPROVED | NPRA | |
| Malaysia | Pigicox 5% Suspension | Range Pharma Sdn. Bhd. | Veterinary | PRODUCT APPROVED | NPRA | |
| Malaysia | Porcox-5 Oral Suspension | Genpharma Sdn. Bhd | Veterinary | PRODUCT APPROVED | NPRA | |
| Malaysia | PVP-Toltrazuril 5% w/v Suspension | Pelangi Vet Pharma Sdn. Bhd. | Veterinary | PRODUCT APPROVED | NPRA | |
| Poland | Baycox | Elanco Animal Health GmbH | 2,5 mg/100 ml | Roztwór doustny | Bezterminowe | URPL RPL |
| Poland | Baycox Multi | Elanco Animal Health GmbH | 50 mg/ml | Zawiesina doustna | Bezterminowe | URPL RPL |
| Poland | Cevazuril | Ceva Animal Health Polska Sp. z o.o. | 50 mg/ml | Zawiesina doustna | Bezterminowe | URPL RPL |
| Poland | Chanox Multi | Chanelle Pharmaceuticals Manufacturing Ltd. | 50 mg/ml | Zawiesina doustna | Bezterminowe | URPL RPL |
| Poland | Cocciklass | Mevet S.a.u. | 50 mg/ml | Zawiesina doustna | Bezterminowe | URPL RPL |
| Poland | Dozuril | Dopharma Research B.V. | 25 mg/ml | Roztwór do podania w wodzie do picia | Bezterminowe | URPL RPL |
| Poland | Dozuril | Dopharma Research B.V. | 50 mg/ml | Zawiesina doustna | Bezterminowe | URPL RPL |
| Poland | Dozuril CT | Dopharma Research B.V. | 25 mg/ml | Roztwór do podania w wodzie do picia | Bezterminowe | URPL RPL |
| United States | Toltrazuril | Medisca Inc. | Powder | FDA NDC | ||
| United States | Toltrazuril | Ngl Fine-Chem Limited | Powder | FDA NDC | ||
| United States | Toltrazuril | Jiangsu Willing Bio-Tech Co., Ltd. | Powder | FDA NDC | ||
| United States | Toltrazuril | Alivira Animal Health Limited | Powder | FDA NDC |
See every manufacturer of Toltrazuril worldwide →
Regulator price references for Toltrazuril
Published list or reimbursement prices for Toltrazuril presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.
| Country | Product | Strength | Pack | Price | Type | Source | As of |
|---|---|---|---|---|---|---|---|
| Iceland | Baycoxine vet | 50mg/1ml | glas | 5,343.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Baycoxine vet | 50mg/1ml | glas | 23,670.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. Because this DIN is marketed in Canada, supply normally comes through the Canadian channel; where the Canadian presentation is short or discontinued, the registrations above show which regulated markets hold an equivalent that can be imported under the Special Access Programme or for clinical comparator use. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Baycox (DIN 02355353) marketed in Canada?
Yes. Health Canada lists DIN 02355353 as Marketed as of 09 Dec 2021.
Who holds the Canadian licence for this product?
Elanco Canada Limited is the company of record in the Health Canada Drug Product Database.
Is Toltrazuril registered outside Canada?
Yes — Nexara Health has matched 53 registrations in 5 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02355353, status date 2021-12-09; national medicine registries: FDA NDC, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, NPRA, URPL RPL; price sources: Lyfjastofnun lyfjaverdskra. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02355353, status date 2021-12-09; national medicine registries: FDA NDC, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, NPRA, URPL RPL; price sources: Lyfjastofnun lyfjaverdskra.
Health Canada Drug Product Database (DPD), DIN 02355353, status date 2021-12-09; national medicine registries: FDA NDC, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, NPRA, URPL RPL; price sources: Lyfjastofnun lyfjaverdskra. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.